Tonix 制药控股公司宣布，其药物Tonmya已与联邦医疗保险（Medicare）达成覆盖协议。此项协议预计将自2027年1月1日起生效，届时将为该药物新增约900万参保人的潜在覆盖范围。
此举标志着Tonmya在获得主流支付方认可方面取得重要进展，有望拓宽其市场准入渠道。协议的生效日期为未来商业化铺平了道路，或将对公司的营收前景产生积极影响。
Tonix 制药控股公司宣布，其药物Tonmya已与联邦医疗保险（Medicare）达成覆盖协议。此项协议预计将自2027年1月1日起生效，届时将为该药物新增约900万参保人的潜在覆盖范围。
此举标志着Tonmya在获得主流支付方认可方面取得重要进展，有望拓宽其市场准入渠道。协议的生效日期为未来商业化铺平了道路，或将对公司的营收前景产生积极影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.